Safety and efficacy of PFO closure devices implantation and clinical outcomes: a single-center long-term review.
Anno:
2024
Introduction. Patent foramen ovale (PFO) is present in up to 25% of the general population, and it is a relevant cause of cryptogenic stroke. The current standard of care for selected patients with PFO and cryptogenic stroke is transcatheter closure, but the risk of post-closure-new-onset atrial fibrillation (AF) has…